← Open Payments lookup

KENBERLY BAUGHMAN: Open Payments

NPI 1275248536 · BOGALUSA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$726 in 7 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $662 · 2025 $726

Food & beverage: $726
CompanyPaymentsAmount
Edwards Lifesciences Corporation1$142
AstraZeneca Pharmaceuticals LP1$131
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$125
Teva Pharmaceuticals USA, Inc.1$121
Bayer Healthcare Pharmaceuticals Inc.1$97
Novo Nordisk Inc1$90
Lundbeck LLC1$19

Products named: AIRSUPRA, CAPLYTA, AUSTEDO XR, Kerendia, Wegovy, REXULTI.

Industry payments across LA — which companies pay providers there.